Melatonin was found to have a small inhibitory effect on tyrosinase activity and a slight stimulatory action on dopachrome tautomerase activity in B16 mouse melanoma cells. These effects were time and dose dependent, with the maximal response being observed after 24-48 h treatment and at concentrations of melatonin higher than the physiologic levels of the circulating hormone. Although these effects on the melanogenic activities were modest, incubation of melanocytes with melatonin prior to the addition of the melanotropin mediated a dramatic inhibition of a-melanocyte-stimulating-hormone-(a-MSH)-induced melanogenesis. This inhibitory effect was evident at melatonin concentrations as low as 10 nM. Inhibition was nearly total at 0.1 mM melatonin, even at high concentrations of a-MSH (1 pM).The inhibitory effect of melatonin on a-MSH stimulation of melanogenesis was investigated. Melatonin appeared to act at least at two stages. Pharmacological concentrations of melatonin diminished the number of a-MSH receptors to about 75% of the control values without an apparent effect on receptor affinity, as determined by receptor-binding studies using '251-[N-Leu4-~-Phe7]a-MSH as a probe. Physiological concentrations of melatonin also appeared to interfere with the intracellular events coupling increased CAMP levels and induction of the c locus tyrosinase, since it strongly inhibited the theophyllinemediated stimulation of melanogenesis. The inhibiton of tyrosinase stimulation was higher in the microsoma1 than in the melanosomal fractions of cells which were treated with melatonin, then exposed to either a-MSH (1 pM) or theophylline (1 mM), suggesting that one of the main effects of melatonin might be inhibition of the induction of tyrosinase de novo synthesis.Keywords : melatonin ; a-melanocyte-stimulating hormone ; tyrosinase ; tyrosinase-related proteins ; melanogenesis.Mammalian pigmentation is the result of melanin production by the epidermal melanocytes. Within melanocytes, melanin synthesis proceeds in specialized organelles, the melanosomes, through a series of coupled enzymic and chemical reactions (reviewed in Prota, 1992). The two initial steps of the pathway, rate-limiting hydroxylation of tyrosine to yield ~-3P-dihydroxyphenylalanine (L-Dopa) and L-Dopa oxidation to L-dopaquinone, are catalyzed by tyrosinase. These two reactions can also be catalyzed, although with lower efficiency, by the tyrosinaserelated protein-1 (TRP1; Jimenez et al., 1991 ; JimCnez-Cervantes et al., 1994) a protein encoded by the b Locus (Jackson, 1988). At least one other enzymic protein, dopachrome tautomerase (Aroca et al., 1990), has been shown to be involved in regulation of the pathway. This enzyme catalyzes the tautomerization of L-dopachrome, the product of spontaneous evolution